Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and risk factors of stroke in the Americas: a comprehensive narrative literature review.

Lancet regional health. Americas·2026
Same author

Implementation of stroke prevention: a review of challenges and opportunities in the Americas.

Lancet regional health. Americas·2026
Same author

Statins May Not Reduce Reoperation Rates in Chronic Subdural Hematoma, Regardless of the Use of Antithrombotic Medication.

Journal of neurological surgery. Part A, Central European neurosurgery·2026
Same author

Suicide mortality among adolescents and young adults aged 10-24 years in the Americas, 2000-2021: an analysis using the WHO Global Health Estimates.

Lancet regional health. Americas·2026
Same author

Correction: Jugel et al. Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers. <i>Cancers</i> 2022, <i>14</i>, 1925.

Cancers·2026
Same author

The rising burden of drug use disorders in the Americas, 2000-2021.

Revista panamericana de salud publica = Pan American journal of public health·2025

Related Experiment Video

Updated: Jun 21, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Different molecular patterns in glioblastoma multiforme subtypes upon recurrence.

Ramon Martinez1, Veit Rohde, Gabriele Schackert

  • 1Department of Neurosurgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. ramon.martinez@med.uni-goettingen.de

Journal of Neuro-Oncology
|August 1, 2009
PubMed
Summary

Glioblastoma (GBM) recurrence is poorly understood. This study reveals that relapsed GBMs either maintain their original molecular profile or acquire a type 2 profile, impacting treatment strategies.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Related Experiment Videos

Last Updated: Jun 21, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Area of Science:

  • Neuro-oncology
  • Cancer Genomics
  • Molecular Pathology

Background:

  • Glioblastoma (GBM) is characterized by frequent recurrence, leading to poor patient prognosis.
  • The molecular mechanisms driving GBM recurrence remain largely unknown.
  • Understanding these mechanisms is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the genetic alterations in recurrent glioblastoma (GBM) compared to their primary tumors.
  • To elucidate the molecular patterns of tumor progression during GBM recurrence.
  • To identify potential therapeutic targets based on molecular profiles of relapsed GBM.

Main Methods:

  • Analysis of 20 paired primary and recurrent GBM samples.
  • Sequencing for p53 and PTEN status.
  • Semiquantitative PCR for EGFR amplification.
  • Microsatellite analysis for genome-wide fingerprinting.

Main Results:

  • Primary GBMs classified into type 1, type 2, or non-type 1-non-type 2.
  • Recurrent GBMs either maintained their original molecular profile (type 1 or type 2) or non-type 1-non-type 2 GBMs acquired a type 2 profile with EGFR amplification.
  • New PTEN mutations and increased Loss of Heterozygosity (LOH) were observed in type 2 recurrent GBMs.

Conclusions:

  • GBM recurrence follows distinct molecular patterns based on the primary tumor's genetic profile.
  • Type 1 and type 2 GBMs show distinct progression pathways upon recurrence.
  • These findings highlight the heterogeneity of GBM recurrence and suggest tailored therapeutic approaches.